{"disease":{"id":"pulmonary-tuberculoses","name":"pulmonary tuberculoses"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05477966","title":"A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress","phase":"","overall_status":"UNKNOWN","enrollment_count":900,"lead_sponsor_name":"Jae-Joon Yim","has_results":false},{"nct_id":"NCT05568368","title":"Time-to-Detection in Culture of Mycobacterium Tuberculosis","phase":"","overall_status":"COMPLETED","enrollment_count":705,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT03896685","title":"Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Médecins Sans Frontières, France","has_results":false},{"nct_id":"NCT07516158","title":"Vitamin D and Immune Response in Pulmonary Tuberculosis With and Without Chronic Pulmonary Aspergillosis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan","has_results":false},{"nct_id":"NCT04930978","title":"Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Tuberculosis Research Centre, India","has_results":false},{"nct_id":"NCT05097638","title":"Lung Health After Tuberculosis: Clinical and Functional Assessment in Post Pulmonary Tuberculosis Egyptian Patients.","phase":"","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05045391","title":"Pulmonary Aspergillosis in Tuberculosis Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan","has_results":false},{"nct_id":"NCT04044001","title":"BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Michael Hoelscher","has_results":false},{"nct_id":"NCT04207112","title":"Economic Evaluation of New MDR TB Regimens","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Medecins Sans Frontieres, Netherlands","has_results":false},{"nct_id":"NCT04085133","title":"Prevalence and Burden of Bronchiectasis in Tuberculous Patients","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07073638","title":"Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Thirty Respiratory Limited","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}